José Javier Aristu Mendioroz-rekin lankidetzan egindako argitalpenak (9)

2019

  1. Erratum: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience (PLoS ONE (2019)14:6 (e0217881)Doi:10.1371/journal.pone.0217881)

    PLoS ONE

  2. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

    PLoS ONE, Vol. 14, Núm. 6

2017

  1. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

2014

  1. Validación de técnicas de segmentación para la tomografía por emisión de positrones mediante imágenes ex-vivo de piezas quirúrgicas oncológicas

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 2, pp. 79-86

2012

  1. Tomografía por emisión de positrones en tumores del sistema nervioso central

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 769-778

2011

  1. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: Volumetric analysis of extent of resection in single-center experience

    Journal of Neuro-Oncology, Vol. 102, Núm. 1, pp. 105-113

  2. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation

    Journal of Nuclear Medicine, Vol. 52, Núm. 6, pp. 865-872

1999

  1. C-11-methionine and F-18-FDG PET in gliomas: A semiquantitative study in the pretherapeutic and posttherapeutic evaluation.

    EUROPEAN JOURNAL OF NUCLEAR MEDICINE

  2. Could <SUP>11</SUP>C-methionine avoid the use of <SUP>18</SUP>F-fluoro-deoxyglucose in brain Pet imaging of gliomas

    11TH EUROPEAN CONGRESS OF NEUROSURGERY